Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ICCC

ImmuCell Corporation

Healthcare · USD

Set alert

Price alert · ICCC

All alert types
10.26 USD -0.28 -2.69%
As of Oct 30, 2026 Extended hours 10.26 0.00%
Bid
10.25 × 2
Ask
10.60 × 2
9.98 Day range 10.36
4.56 52-week range 11.72
YTD
+66.83%
1 year
+68.47%
Open
10.25
Prev close
10.54
Mkt cap
93.18M
Vol
11.02K
Avg vol
18.05K
EPS
0.07
P/E
146.57
Div yield
0.00%
More statistics
Low
9.98
High
10.36
Forward P/E
-42.82
Beta
0.57
Short ratio
0.23
Inst. own
14.51%
Dividend
0.00
Ex-div date
50-d avg
3.93
200-d avg
4.28
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ICCC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.49 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -51.3×
FY 2016: 49.6×FY 2017: -259×FY 2018: -16.8×FY 2019: -27.1×FY 2020: -42.5×FY 2021: -777×FY 2022: -19.1×FY 2023: -6.8×FY 2024: -19.8×FY 2025: -51.3×
FY 2016 5y median -19.8× FY 2025
P/S 2.0×
FY 2016: 2.6×FY 2017: 4.2×FY 2018: 3.5×FY 2019: 2.6×FY 2020: 2.8×FY 2021: 3.2×FY 2022: 2.5×FY 2023: 2.2×FY 2024: 1.6×FY 2025: 2.0×
FY 2016 5y median 2.2× FY 2025
P/B 2.1×
FY 2016: 1.3×FY 2017: 1.8×FY 2018: 1.8×FY 2019: 1.2×FY 2020: 1.5×FY 2021: 1.9×FY 2022: 1.6×FY 2023: 1.6×FY 2024: 1.5×FY 2025: 2.1×
FY 2016 5y median 1.6× FY 2025
P/FCF 45.3×
FY 2016: -6.4×FY 2017: -2.6×FY 2018: -16.1×FY 2019: -30.3×FY 2020: -15.6×FY 2021: -36.7×FY 2022: -8.6×FY 2023: -6.0×FY 2024: -390×FY 2025: 45.3×
FY 2016 5y median -8.6× FY 2025
EV/EBITDA 30.3×
FY 2016: 13.4×FY 2017: 71.1×FY 2018: 519×FY 2019: 26.0×FY 2020: 28.0×FY 2021: 22.5×FY 2022: 154×FY 2023: -21.9×FY 2024: 50.1×FY 2025: 30.3×
FY 2016 5y median 30.3× FY 2025
EV/Sales 2.3×
FY 2016: 2.4×FY 2017: 4.7×FY 2018: 4.2×FY 2019: 2.7×FY 2020: 3.0×FY 2021: 3.2×FY 2022: 2.9×FY 2023: 3.1×FY 2024: 2.0×FY 2025: 2.3×
FY 2016 5y median 2.9× FY 2025
FCF Yield 2.2%
FY 2016: -15.6%FY 2017: -38.1%FY 2018: -6.2%FY 2019: -3.3%FY 2020: -6.4%FY 2021: -2.7%FY 2022: -11.7%FY 2023: -16.8%FY 2024: -0.3%FY 2025: 2.2%
FY 2016 5y median -2.7% FY 2025

Profitability

Gross Margin 41.4%
FY 2016: 56.8%FY 2017: 50.1%FY 2018: 47.3%FY 2019: 49.1%FY 2020: 44.7%FY 2021: 45.0%FY 2022: 41.2%FY 2023: 25.2%FY 2024: 30.0%FY 2025: 41.4%
FY 2016 5y median 41.2% FY 2025
Operating Margin 6.0%
FY 2016: 9.3%FY 2017: -2.3%FY 2018: -13.2%FY 2019: -7.0%FY 2020: -9.0%FY 2021: 1.3%FY 2022: -12.4%FY 2023: -32.9%FY 2024: -6.2%FY 2025: 6.0%
FY 2016 5y median -6.2% FY 2025
Net Margin -3.8%
FY 2016: 5.3%FY 2017: -1.6%FY 2018: -21.1%FY 2019: -9.4%FY 2020: -6.7%FY 2021: -0.4%FY 2022: -13.4%FY 2023: -33.1%FY 2024: -8.1%FY 2025: -3.8%
FY 2016 5y median -8.1% FY 2025
ROE -3.8%
FY 2016: 2.6%FY 2017: -0.7%FY 2018: -10.7%FY 2019: -4.5%FY 2020: -3.6%FY 2021: -0.2%FY 2022: -8.2%FY 2023: -23.1%FY 2024: -7.8%FY 2025: -3.8%
FY 2016 5y median -7.8% FY 2025
ROIC 4.1%
FY 2016: 2.6%FY 2017: -0.3%FY 2018: -4.6%FY 2019: -2.5%FY 2020: -3.5%FY 2021: 0.6%FY 2022: -5.4%FY 2023: -13.8%FY 2024: -3.8%FY 2025: 4.1%
FY 2016 5y median -3.8% FY 2025
ROA -2.4%
FY 2016: 2.1%FY 2017: -0.5%FY 2018: -7.1%FY 2019: -3.3%FY 2020: -2.5%FY 2021: -0.2%FY 2022: -5.6%FY 2023: -13.2%FY 2024: -4.8%FY 2025: -2.4%
FY 2016 5y median -4.8% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2016: -6.7%FY 2017: 9.3%FY 2018: 5.3%FY 2019: 24.9%FY 2020: 11.8%FY 2021: 25.4%FY 2022: -3.5%FY 2023: -5.9%FY 2024: 51.6%FY 2025: 4.3%
FY 2016 FY 2025
Operating Income 200.6%
FY 2016: -58.1%FY 2017: -127.3%FY 2018: -495.5%FY 2019: 34.1%FY 2020: -44.7%FY 2021: 118.7%FY 2022: -993.2%FY 2023: -150.0%FY 2024: 71.5%FY 2025: 200.6%
FY 2016 FY 2025
EPS (diluted) 53.8%
FY 2016: -68.4%FY 2017: -128.3%FY 2018: -1138.9%FY 2019: 54.8%FY 2020: 26.3%FY 2021: 92.6%FY 2022: -3006.8%FY 2023: -134.4%FY 2024: 65.3%FY 2025: 53.8%
FY 2016 FY 2025
Free Cash Flow 1236.0%
FY 2016: -2259.8%FY 2017: -324.1%FY 2018: 85.5%FY 2019: 51.8%FY 2020: -138.1%FY 2021: 40.0%FY 2022: -233.6%FY 2023: -19.0%FY 2024: 98.4%FY 2025: 1236.0%
FY 2016 FY 2025

Financial Health

Current Ratio 4.3×
FY 2016: 7.0×FY 2017: 3.6×FY 2018: 2.5×FY 2019: 5.3×FY 2020: 5.5×FY 2021: 6.4×FY 2022: 4.6×FY 2023: 2.7×FY 2024: 3.4×FY 2025: 4.3×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 1.9×
FY 2016: 5.9×FY 2017: 2.6×FY 2018: 1.6×FY 2019: 4.3×FY 2020: 4.6×FY 2021: 5.2×FY 2022: 2.6×FY 2023: 0.9×FY 2024: 1.8×FY 2025: 1.9×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 0.5×
FY 2016: 0.2×FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.7×FY 2024: 0.5×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 4.4×
FY 2016: -1.2×FY 2017: 7.5×FY 2018: 81.9×FY 2019: 1.5×FY 2020: 1.7×FY 2021: 0.0×FY 2022: 19.1×FY 2023: -6.3×FY 2024: 10.6×FY 2025: 4.4×
FY 2016 5y median 4.4× FY 2025
Interest Coverage 3.8×
FY 2016: 5.5×FY 2017: -1.1×FY 2018: -3.4×FY 2019: -2.2×FY 2020: -3.3×FY 2021: 0.8×FY 2022: -6.6×FY 2023: -12.7×FY 2024: -2.9×FY 2025: 3.8×
FY 2016 5y median -2.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31